Lee's Pharmaceutical Limited
Stories
-
Lee's Pharmaceutical posts results of Phase 3 ciprofloxacin-fluocinolone otic solution trial
The study enrolled 600 participants and was completed in October 2021. It evaluated the efficacy and safety of ciprofloxacin 0.3% plus fluocinolone acetonide 0.025% otic solution versus ciprofloxacin 0.3% alone in acute otitis externa.